Merck & Co Inc at Bank of America Healthcare Conference Transcript
Welcome to the second day of the Bank of America Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here. And we're thrilled today to have Merck on stage with us, and we have Caroline Litchfield. Caroline, welcome.
Thank you. Excited to be here and thanks for joining this session.
Questions & Answers
It's great to do these in person now. I know we've all been pretty tired of Zoom. But let's talk sort of higher level. A lot of the questions on Merck that we've got, and I'm sure a lot of the ones you've gotten are your oncology business is very successful, but it's just grown in concentration. And today's sort of TIGIT news kind of shows that drug development is a risky business. But how are you thinking about that on the back of the Organon spin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
